Effectiveness of a new slimming drug – Saxenda has been studied for three years. The results of long-term studies of Saxenda were analyzed by the employees of:
• Health Canada
• European Medicines Agency
• Food and Drug Administration (USA)
The analysis of study results has confirmed that Saxenda provides a significant weight loss, and its effectiveness exceeds potential health risks. In the USA, Canada and Europe, Saxenda is approved to treat exogenous obesity:
• In overweight patients with BMI of 27 to 29.9
• In obese patients with BMI of 30 and greater
The study results have demonstrated that Saxenda drug helps not only to lose weight, but also to reduce cardiometabolic risks.
Given the fact that Saxenda effectively reduces body weight and not less effectively decreases the blood sugar level, its use helps delay the onset of type 2 diabetes, as well as reduce the risk of diabetes by no less than 80%.
It should be noted that Saxenda contains active ingredient Liraglutide, which has been used as an anti-diabetic agent for over 5 years. In the USA, Liraglutide-containing antidiabetic drug is available under the brand Victoza.
• The range of effective daily doses of Victoza (Liraglutide) for diabetes treatment varies from the initial dose of 0.6mg up to the maximum dose of 1.8mg.
• The standard therapeutic dose of Saxenda (Liraglutide) for the obesity treatment is 3mg.
Just as Saxenda solution for injections, Victoza solution is injected under the skin by means of dispenser pen. The maximum single dose, which can be injected by means of Victoza pen, is 1.8mg.
Thus, Liraglutide-containing drug – Victoza cannot be used for the obesity treatment and should be prescribed only to patients with type 2 diabetes.
• The FDA (USA) confirmed Saxenda effectiveness and approved this drug for the obesity treatment on December 23, 2014.
• Health Canada confirmed Saxenda effectiveness and approved this weight loss drug on February 26, 2015.
• EMA confirmed Saxenda effectiveness and approved this slimming drug on March 23, 2015.
In June 2015, it is possible to buy Saxenda only in the USA. Information in what countries Saxenda sales will be launched in 2015-2016 you can find in the following reviews.